Study S000096

The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03426085
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: TRIPLE
Status: UNKNOWN
Enrollment: 44
Start: 2016-05
Primary completion: 2020-04
Lead sponsor: Eastern Virginia Medical School
Conditions: Autonomic Nervous System Diseases; Sweat Gland Diseases; Diabetic Neuropathy With Neurologic Complication
Interventions: DRUG:Liraglutide 6 mg Solution for Injection; OTHER:Placebo
Results posted: FALSE

Registered primary outcomes

Sudomotor Function [One Year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.